secwatch.observer — SEC 8-K summary
======================================

Issuer:     Skye Bioscience, Inc. (SKYE)
CIK:        0001516551
Form:       8-K
Filed at:   2024-03-13T23:59:59+00:00
Accession:  0001516551-24-000045
Event type: other_material
Sentiment:  neutral
Materiality: 0.80
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Skye Bioscience raises $40M via PIPE of 4M shares at $10 each
-------------------------------------------------------------

- Issued 4,000,000 shares at $10.00 per share for gross proceeds of $40,000,000.
- Piper Sandler led placement; Oppenheimer & Co. co-placement agent.
- PIPE closed March 13, 2024; warrants amendment adds cashless exercise through Sept 2025.
- Directors/officers entered 90-day lock-up agreements; registration rights file within 60 days.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1516551/000151655124000045/0001516551-24-000045-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1516551/000151655124000045/skye-20240311.htm
  HTML page:      https://secwatch.observer/filing/0001516551-24-000045

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer